S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
S&P 500   2,966.15 (-0.14%)
DOW   26,787.36 (-0.11%)
QQQ   191.09 (-0.01%)
AAPL   235.87 (-0.14%)
FB   183.28 (-0.49%)
MSFT   139.55 (-0.09%)
GOOGL   1,217.77 (+0.17%)
AMZN   1,736.43 (+0.26%)
CGC   18.86 (-2.93%)
NVDA   186.53 (+0.29%)
MU   44.86 (-0.53%)
BABA   171.16 (-1.03%)
GE   8.72 (-0.91%)
TSLA   256.96 (+3.66%)
AMD   30.53 (+2.62%)
T   37.47 (-0.29%)
F   8.82 (+0.46%)
ACB   3.51 (-4.62%)
PRI   121.47 (-0.18%)
NFLX   285.53 (+0.92%)
BAC   29.14 (+0.80%)
GILD   64.51 (+0.81%)
DIS   129.70 (-0.25%)
Log in

Loxo Oncology SEC Filings & 10K Form (NASDAQ:LOXO)

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume400 shs
Average Volume565,561 shs
Market Capitalization$7.18 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.51

SEC Filings

Loxo Oncology (NASDAQ:LOXO) SEC Filings

DateFilerForm TypeView
02/25/2019
10:28 AM
Loxo Oncology (Filer)
Form 15-12B
02/21/2019
11:15 PM
Loxo Oncology (Filer)
Form EFFECT
02/15/2019
3:55 PM
Loxo Oncology (Filer)
Form S-8 POS
02/15/2019
3:51 PM
Loxo Oncology (Filer)
Form S-8 POS
02/15/2019
3:49 PM
Loxo Oncology (Filer)
Form S-8 POS
02/15/2019
3:47 PM
Loxo Oncology (Filer)
Form S-8 POS
02/15/2019
3:46 PM
Loxo Oncology (Filer)
Form S-8 POS
02/15/2019
3:41 PM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2019
3:39 PM
Loxo Oncology (Filer)
Form POSASR
02/15/2019
3:36 PM
Loxo Oncology (Filer)
Form POS AM
02/15/2019
3:05 PM
AISLING CAPITAL III LP (Filed by)
Loxo Oncology (Subject)
Form SC 13D/A
02/15/2019
8:23 AM
Loxo Oncology (Subject)
Form SC 14D9/A
02/15/2019
8:20 AM
LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
Form SC TO-T/A
02/15/2019
8:18 AM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:17 AM
Loxo Oncology (Issuer)
Nanda Nisha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:16 AM
Loxo Oncology (Issuer)
Naider Avi Z. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:15 AM
Loxo Oncology (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
02/15/2019
8:14 AM
Loxo Oncology (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:14 AM
Kunkel Lori Anne (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:13 AM
Harr Steve (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:12 AM
Fuhrman Alan (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:11 AM
Flaherty Keith T. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:09 AM
ELMS STEVE (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:07 AM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:06 AM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
12:51 PM
Loxo Oncology (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
02/13/2019
1:08 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Loxo Oncology (Subject)
Form SC 13G/A
02/12/2019
8:58 AM
Loxo Oncology (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/11/2019
12:59 PM
Loxo Oncology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/11/2019
8:14 AM
FMR LLC (Filed by)
Loxo Oncology (Subject)
Form SC 13G/A
02/08/2019
11:33 AM
FMR LLC (Filed by)
Loxo Oncology (Subject)
Form SC 13G/A
02/06/2019
2:03 PM
BlackRock Inc. (Filed by)
Loxo Oncology (Subject)
Form SC 13G/A
02/05/2019
3:00 PM
Loxo Oncology (Subject)
Form SC 14D9/A
02/01/2019
6:18 AM
Loxo Oncology (Subject)
Form SC 14D9/A
02/01/2019
6:16 AM
LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
Form SC TO-T/A
01/17/2019
7:08 AM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4/A
01/17/2019
7:06 AM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4/A
01/17/2019
6:37 AM
Loxo Oncology (Subject)
Form SC 14D9
01/17/2019
6:35 AM
LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
Form SC TO-T
01/15/2019
3:08 PM
LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
Form SC 13D
01/15/2019
7:30 AM
AISLING CAPITAL III LP (Filed by)
Loxo Oncology (Subject)
Form SC 13D/A
01/10/2019
2:25 PM
Loxo Oncology (Subject)
SANDS CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
01/08/2019
4:08 PM
LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
Form SC TO-C
01/07/2019
4:09 PM
Loxo Oncology (Subject)
Form SC14D9C
01/07/2019
1:59 PM
LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
Form SC TO-C
01/07/2019
6:14 AM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2019
4:08 PM
Loxo Oncology (Issuer)
Nanda Nisha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:06 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:04 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:03 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:02 PM
Loxo Oncology (Issuer)
Nanda Nisha (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
3:30 PM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
4:07 PM
Loxo Oncology (Issuer)
Naider Avi Z. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
4:17 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
4:14 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
4:12 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
3:30 PM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2018
4:13 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2018
4:09 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2018
4:08 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
5:01 AM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
3:31 PM
Loxo Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
5:45 AM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2018
3:46 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
3:44 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
3:42 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2018
5:45 AM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2018
5:19 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
5:17 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
5:14 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
4:27 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
4:25 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
4:23 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
3:39 PM
Loxo Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/09/2018
3:03 PM
Loxo Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2018
5:46 AM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2018
3:45 PM
AISLING CAPITAL III LP (Filed by)
Loxo Oncology (Subject)
Form SC 13D/A
07/12/2018
3:45 PM
AISLING CAPITAL III LP (Reporting)
Aisling Capital Partners III LLC (Reporting)
Aisling Capital Partners III LP (Reporting)
ELMS STEVE (Reporting)
Loxo Oncology (Issuer)
Purcell Dennis J (Reporting)
SCHIFF ANDREW N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2018
4:04 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2018
4:03 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2018
4:01 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2018
9:52 AM
FMR LLC (Filed by)
Loxo Oncology (Subject)
Form SC 13G/A
06/21/2018
4:04 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
4:03 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
4:02 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
4:00 PM
Kunkel Lori Anne (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:10 PM
Loxo Oncology (Issuer)
Naider Avi Z. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:07 PM
Loxo Oncology (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:05 PM
Kunkel Lori Anne (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:04 PM
Harr Steve (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:03 PM
Fuhrman Alan (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:02 PM
Flaherty Keith T. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:01 PM
ELMS STEVE (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:00 PM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
5:02 PM
Loxo Oncology (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
5:01 PM
Fuhrman Alan (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
5:00 PM
Flaherty Keith T. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
5:46 AM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2018
3:46 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2018
3:45 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel